rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    INKT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      MiNK Therapeutics, Inc. Q3 2026 Earnings Call Summary
      Nov 11Yahoo FinanceINKT
      MiNK Therapeutics Inc (INKT) Q1 2026 Earnings Call Highlights: Prolonged Survival in Gastric ...
      Nov 11Yahoo FinanceINKT
      What MiNK Therapeutics (INKT) Said on Its Q3 Earnings Call
      Nov 11Yahoo FinanceINKT
      MiNK Therapeutics Q3 2026 Earnings Call Transcript
      Nov 11BenzingaINKT
      MiNK Therapeutics stock initiated at buy by H.C. Wainwright
      Nov 4Investing.comINKT
      MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
      Nov 2Yahoo FinanceINKT
      Mink Therapeutics CEO Buell sells $73,265 in stock for tax obligations
      Oct 15Investing.comINKT
      MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026
      Oct 2Yahoo FinanceINKT
      MiNK’s iNKT platform selected for $87M ARPA-H program
      Sep 30Investing.comINKT
      MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
      Sep 30Yahoo FinanceINKT

      This is the newest page. Registered accounts read further back.